Work

Supplementary Table S5 from Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Year: 2024
Type: supplementary-materials
Abstract: Supplementary Table S5. Checkpoint inhibitor (CPI) classes and therapeutic combinations received by study participants.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4400214900
Cites:
Cited by:
Related to: 10